Image Evaluation of Intalight Dream OCTA Scans With Optos FA & ICGA Images
for Retina Pathology
1 location in Houston
Sponsor: Intalight, Inc
Sex: All·Age: 22+
Code: NCT07568704·Recruiting·Listed May 2026
Paid Clinical Trials in Texas
Texas has 5,344 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
4,652 clinical trials
Get a weekly email when new trials open in Houston, TX.
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for Chronic Lymphocytic Leukemia
Drug: Sonrotoclax
Sites in Tyler +20 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT07277231·Phase 3·Recruiting·Listed Dec 2025
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
for Hemophilia
Sites in Dallas +4 more locations
Sponsor: Sanofi
Sex: Male·Age: 1 - 11
Code: NCT07285460·Phase 3·Recruiting·Listed Dec 2025
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
for Non-small Cell Lung Cancer (NSCLC)
Sites in Dallas, San Antonio +7 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT07349537·Phase 1·Recruiting·Listed Jan 2026
Confirmatory Clinical Study in Active Ulcerative Colitis
for Colitis, Ulcerative
Sites in San Antonio +5 more locations
Sponsor: MRM Health NV
Sex: All·Age: 16+
Code: NCT07296315·Phase 2·Recruiting·Listed Dec 2025
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
for Advanced Solid Tumors
Sites in San Antonio +4 more locations
Sponsor: Ottimo Pharma Limited
Sex: All·Age: 18+
Code: NCT07266428·Phase 1, Phase 2·Recruiting·Listed Dec 2025
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
for Advanced Breast Cancer
Sites in Houston, San Antonio +11 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07318805·Phase 1·Recruiting·Listed Jan 2026
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
for Advanced Malignant Solid Tumor
Sites in Houston, Dallas +2 more locations
Sponsor: Pilatus Biosciences Inc
Sex: All·Age: 18+
Code: NCT07337525·Phase 1·Recruiting·Listed Jan 2026
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
for Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Sites in Dallas +9 more locations
Sponsor: Airiver Medical, Inc.
Sex: All·Age: 18+
Code: NCT07290140·Recruiting·Listed Dec 2025
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
for Pompe Disease (Late-onset)
Sites in Dallas +8 more locations
Sponsor: AskBio Inc
Sex: All·Age: 18 - 65
Code: NCT07282847·Phase 1, Phase 2·Recruiting·Listed Dec 2025
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
for Ewing Sarcoma
Sites in Houston +5 more locations
Sponsor: Amgen
Sex: All·Age: 2+
Code: NCT07297979·Phase 1·Recruiting·Listed Dec 2025
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
for Advanced HR+/HER2- Breast Cancer
Drug: GVV858
Sites in San Antonio +2 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07288359·Phase 1, Phase 2·Recruiting·Listed Dec 2025
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
for Refractory Melanoma
Sites in Dallas +7 more locations
Sponsor: Diakonos Oncology Corporation
Sex: All·Age: 18+
Code: NCT07288112·Phase 1, Phase 2·Recruiting·Listed Dec 2025
Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis
for Rheumatoid Arthritis
Sites in Dallas, Irving & Colleyville
Sponsor: Surf Therapeutics
Sex: All·Age: 18+
Code: NCT07293871·Recruiting·Listed Dec 2025
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
for Malignant Neoplasm
Drug: MK-4716
Sites in Irving +2 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07247110·Phase 1·Recruiting·Listed Nov 2025
A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.
for Malocclusion
Sites in Frisco +3 more locations
Sponsor: Dentsply Sirona Implants and Consumables
Sex: All·Age: 18+
Code: NCT07290790·Recruiting·Listed Dec 2025
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
for Cancer
Drug: SYS6043
Sites in San Antonio, Austin +3 more locations
Sponsor: Conjupro Biotherapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07424547·Phase 1·Recruiting·Listed Feb 2026
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
for Aortic Valve Stenosis
Sites in San Antonio +6 more locations
Sponsor: EmStop Inc
Sex: All·Age: 22+
Code: NCT07276711·Recruiting·Listed Dec 2025
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
for Diffuse Cutaneous Systemic Sclerosis
Sites in Houston, Dallas +21 more locations
Sponsor: Mediar Therapeutics
Sex: All·Age: 18+
Code: NCT07287670·Phase 2·Recruiting·Listed Dec 2025
Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
for Stargardt Disease
Drug: RTx-021
Sites in Bellaire +2 more locations
Sponsor: Ray Therapeutics, Inc.
Sex: All·Age: 16+
Code: NCT07439887·Phase 1, Phase 2·Recruiting·Listed Feb 2026
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria
for Phenylketonuria
Sites in Dallas +2 more locations
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All·Age: 18 - 69
Code: NCT07241234·Phase 1·Recruiting·Listed Nov 2025
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for Chronic Lymphocytic Leukemia
Sites in Fort Worth, Kyle +7 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07218341·Phase 4·Recruiting·Listed Oct 2025
Ambulatory Long Length URodynamics Evaluation
for Urology
Sites in Arlington +6 more locations
Sponsor: Bright Uro
Sex: All·Age: 22+
Code: NCT07425015·Recruiting·Listed Feb 2026
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
for Advanced Squamous Tumors
Sites in Irving +5 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07241039·Phase 1·Recruiting·Listed Nov 2025
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
for Ovarian Cancer
Drug: Bevacizumab
Sites in San Antonio +4 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07278336·Phase 1·Recruiting·Listed Dec 2025
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
for Bipolar I Disorder
Drug: NBI-1117568
Sites in Austin +8 more locations
Sponsor: Neurocrine Biosciences
Sex: All·Age: 18 - 65
Code: NCT07288320·Phase 2·Recruiting·Listed Dec 2025
Knee Flexionater to Avoid Motion Restoring Surgery
for Joint Contractures
1 location in Houston
Sponsor: Ermi LLC
Sex: All·Age: 40+
Code: NCT07454356·Recruiting·Listed Mar 2026
Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
for Non-infectious Anterior Uveitis
Sites in McAllen +5 more locations
Sponsor: Novaliq GmbH
Sex: All·Age: 18+
Code: NCT07285070·Phase 2·Recruiting·Listed Dec 2025
Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
for Colorectal Cancer
Sites in Houston +1 more location
Sponsor: GI Windows, Inc.
Sex: All·Age: 22+
Code: NCT07276529·Recruiting·Listed Dec 2025
A Study of BI 3810944 in Patients With Advanced Cancer
for Solid Tumours
Sites in Houston +3 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07224425·Phase 1·Recruiting·Listed Nov 2025
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
for Colorectal Cancer
Sites in San Antonio +4 more locations
Sponsor: PAQ Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07300150·Phase 1·Recruiting·Listed Dec 2025
Continuous Observational Monitoring Program for Allay™ Hydrogel Cap Safety and Success Study
for Peripheral Nerve Injuries
Sites in Denton +3 more locations
Sponsor: Tulavi Therapeutics,Inc.
Sex: All·Age: All ages
Code: NCT07246980·Recruiting·Listed Nov 2025
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
for Diabetes Mellitus, Type 1
Drug: Baricitinib
Sites in Corpus Christi +4 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 1 - 35
Code: NCT07222332·Phase 3·Recruiting·Listed Oct 2025
A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors
for Advanced-stage Solid Tumors
Sites in Irving +1 more location
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07223125·Phase 1·Recruiting·Listed Oct 2025
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
for Atopic Keratoconjunctivitis
Drug: DFL24498
Sites in Houston +7 more locations
Sponsor: Dompé Farmaceutici S.p.A
Sex: All·Age: 18 - 65
Code: NCT07395232·Phase 3·Recruiting·Listed Feb 2026
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
for Chronic Lymphocytic Leukemia
Drug: Emavusertib
Sites in Dallas +5 more locations
Sponsor: Curis, Inc.
Sex: All·Age: 18+
Code: NCT07271667·Phase 2·Recruiting·Listed Dec 2025
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
for Peanut Allergies
Sites in Houston, Dallas +6 more locations
Sponsor: Mabylon AG
Sex: All·Age: 12 - 55·Accepts healthy volunteers
Code: NCT07287033·Phase 1·Recruiting·Listed Dec 2025
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
for Locally Advanced Solid Tumor
Sites in Houston, San Antonio +4 more locations
Sponsor: Ipsen
Sex: All·Age: 18+
Code: NCT07213817·Phase 1, Phase 2·Recruiting·Listed Oct 2025
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
for Advanced Solid Tumor
Sites in Houston +6 more locations
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT07226349·Phase 1·Recruiting·Listed Nov 2025
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
for Depressive Disorder, Major
Sites in Houston +9 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 12 - 17
Code: NCT07227454·Phase 3·Recruiting·Listed Nov 2025